{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:40:52Z","timestamp":1768009252049,"version":"3.49.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.mce.2011.05.010","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T20:50:07Z","timestamp":1307307007000},"page":"61-69","source":"Crossref","is-referenced-by-count":48,"title":["Vitamin D metabolism and action in the prostate: Implications for health and disease"],"prefix":"10.1016","volume":"347","author":[{"given":"Srilatha","family":"Swami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna V.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.105.568451","article-title":"Cyclooxygenase inhibition and cardiovascular risk","volume":"112","author":"Antman","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.mce.2011.05.010_b0010","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1158\/1078-0432.CCR-07-4274","article-title":"Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer","volume":"14","author":"Attia","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.mce.2011.05.010_b0015","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-06-1039","article-title":"Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice","volume":"12","author":"Banach-Petrosky","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.mce.2011.05.010_b0020","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/ijc.23460","article-title":"Protective role of 1alpha,25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells","volume":"122","author":"Bao","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.mce.2011.05.010_b0025","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/sj.onc.1201469","article-title":"Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line","volume":"15","author":"Barboule","year":"1997","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0030","first-page":"265","article-title":"25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells","volume":"9","author":"Barreto","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/1535-7163.373.3.3","article-title":"Calcitriol in cancer treatment: from the lab to the clinic","volume":"3","author":"Beer","year":"2004","journal-title":"Mol. Cancer Ther."},{"issue":"4A","key":"10.1016\/j.mce.2011.05.010_b0050","first-page":"2647","article-title":"Calcitriol in the treatment of prostate cancer","volume":"26","author":"Beer","year":"2006","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0040","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.11179","article-title":"High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma","volume":"97","author":"Beer","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2006.06.8197","article-title":"Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators","volume":"25","author":"Beer","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.mce.2011.05.010_b0035","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/cncr.23461","article-title":"C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial","volume":"112","author":"Beer","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1172\/JCI111995","article-title":"Evidence for alteration of the vitamin D-endocrine system in blacks","volume":"76","author":"Bell","year":"1985","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0065","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-5347(05)67875-5","article-title":"Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines","volume":"163","author":"Blagosklonny","year":"2000","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/en.141.1.10","article-title":"Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2","volume":"141","author":"Blutt","year":"2000","journal-title":"Endocrinology"},{"issue":"21","key":"10.1016\/j.mce.2011.05.010_b0075","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0080","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/cncr.24973","article-title":"Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer","volume":"116","author":"Chadha","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tem.2003.09.004","article-title":"Vitamin D and prostate cancer prevention and treatment","volume":"14","author":"Chen","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0090","first-page":"901","article-title":"The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer","volume":"6","author":"Chen","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcb.10342","article-title":"Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer","volume":"88","author":"Chen","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0100","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1210\/endo-117-5-2203","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells","volume":"117","author":"Costa","year":"1985","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mc.10053","article-title":"Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells","volume":"34","author":"Davis","year":"2002","journal-title":"Mol. Carcinog."},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0110","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"Deeb","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/erc.1.00920","article-title":"Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells","volume":"12","author":"Dwivedi","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"issue":"3\u20135","key":"10.1016\/j.mce.2011.05.010_b0130","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jsbmb.2006.12.014","article-title":"Role of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cells","volume":"103","author":"Dwivedi","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0090-4295(01)01304-8","article-title":"Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging","volume":"58","author":"Fang","year":"2001","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-0760(03)00063-3","article-title":"Genistein inhibits Vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells","volume":"84","author":"Farhan","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1210\/edrv-7-4-409","article-title":"Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis","volume":"7","author":"Feldman","year":"1986","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2011.05.010_b0150","series-title":"Osteoporosis","first-page":"257","article-title":"Vitamin D: biology, action and clinical implications","author":"Feldman","year":"2001"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cncr.21982","article-title":"A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer","volume":"107","author":"Flaig","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mam.2008.07.003","article-title":"Molecular actions of vitamin D contributing to cancer prevention","volume":"29","author":"Fleet","year":"2008","journal-title":"Mol. Aspects Med."},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0165","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.juro.2009.01.031","article-title":"Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume","volume":"181","author":"Fowke","year":"2009","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(01)00663-3","article-title":"Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate","volume":"186","author":"Fritz","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/9.3.227","article-title":"Do sunlight and vitamin D reduce the likelihood of colon cancer?","volume":"9","author":"Garland","year":"1980","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0180","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0090-4295(97)00408-1","article-title":"Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system","volume":"50","author":"Getzenberg","year":"1997","journal-title":"Urology"},{"issue":"21","key":"10.1016\/j.mce.2011.05.010_b0185","first-page":"4687","article-title":"Androgen-independent prostate cancer progression in the TRAMP model","volume":"57","author":"Gingrich","year":"1997","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.annepidem.2007.12.002","article-title":"Vitamin D and cancer incidence in the Harvard cohorts","volume":"19","author":"Giovannucci","year":"2009","journal-title":"Ann. Epidemiol."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinternmed.2008.525","article-title":"Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure","volume":"169","author":"Gislason","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0200","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1210\/jcem-63-3-766","article-title":"Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D","volume":"63","author":"Glass","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4A","key":"10.1016\/j.mce.2011.05.010_b0205","first-page":"2531","article-title":"Vitamin D compounds: activity against microbes and cancer","volume":"26","author":"Gombart","year":"2006","journal-title":"Anticancer Res."},{"issue":"9458","key":"10.1016\/j.mce.2011.05.010_b0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)17864-7","article-title":"Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study","volume":"365","author":"Graham","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0220","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0022-5347(01)63236-1","article-title":"Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)","volume":"159","author":"Gross","year":"1998","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0225","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1158\/0008-5472.CAN-03-2422","article-title":"Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model","volume":"64","author":"Gupta","year":"2004","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.mce.2011.05.010_b0230","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G","article-title":"Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation","volume":"70","author":"Hanchette","year":"1992","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0235","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2010-2230","article-title":"Vitamin D(3) is more potent than vitamin D(2) in humans","volume":"96","author":"Heaney","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0240","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1464-410X.1998.00769.x","article-title":"Growth inhibition of prostate cell lines in vitro by phyto-oestrogens","volume":"82","author":"Hempstock","year":"1998","journal-title":"Br. J. Urol."},{"issue":"17","key":"10.1016\/j.mce.2011.05.010_b0245","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1200\/JCO.2010.30.9880","article-title":"Vitamin D receptor protein expression in tumor tissue and prostate cancer progression","volume":"29","author":"Hendrickson","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0255","first-page":"1043","article-title":"Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis","volume":"7","author":"Hershberger","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.mce.2011.05.010_b0250","first-page":"821","article-title":"Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression","volume":"1","author":"Hershberger","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mce.2011.05.010_b0260","series-title":"Vitamin D","first-page":"1379","article-title":"Extra-renal 1a-hydroxylate activity and human disease","author":"Hewison","year":"2005"},{"issue":"1\u20132","key":"10.1016\/j.mce.2011.05.010_b0265","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jsbmb.2010.03.081","article-title":"Glucocorticoid regulation of the vitamin D receptor","volume":"121","author":"Hidalgo","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.mce.2011.05.010_b0270","first-page":"2852","article-title":"Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition","volume":"61","author":"Hsu","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.05.010_b0275","doi-asserted-by":"crossref","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"issue":"27","key":"10.1016\/j.mce.2011.05.010_b0280","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1021\/jm040129+","article-title":"Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3)","volume":"47","author":"Kahraman","year":"2004","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.ju.0000132122.93436.aa","article-title":"Genetically modified mice and their use in developing therapeutic strategies for prostate cancer","volume":"172","author":"Kasper","year":"2004","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0300","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1097-0045(19991101)41:3<181::AID-PROS5>3.0.CO;2-7","article-title":"Effect of prenatal vitamin D (calcitriol) exposure on the growth and development of the prostate","volume":"41","author":"Konety","year":"1999","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0295","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0022-5347(05)67112-1","article-title":"In vitro and in vivo effects of vitamin D (calcitriol) administration on the normal neonatal and prepubertal prostate","volume":"164","author":"Konety","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.mce.2011.05.010_b0305","series-title":"Adult and Pediatric Urology","first-page":"1575","article-title":"Carcinoma of the prostate","author":"Kozlowski","year":"1995"},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0090-4295(99)00103-X","article-title":"Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture","volume":"54","author":"Krill","year":"1999","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0310","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jcb.1185","article-title":"Expression patterns of vitamin D receptor in human prostate","volume":"82","author":"Krill","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mce.2011.05.010_b0320","series-title":"Vitamin D","first-page":"179","article-title":"Regulation of vitamin D receptor abundance","author":"Krishnan","year":"1997"},{"key":"10.1016\/j.mce.2011.05.010_b0325","series-title":"Vitamin D: Physiology, Molecular Biology and Clinical Applications","first-page":"1087","article-title":"Anti-inflammatory activity of calcitriol that contributes to its therapeutic and chemopreventive effects in prostate cancer","author":"Krishnan","year":"2010"},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0330","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1677\/ERC-09-0139","article-title":"Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment","volume":"17","author":"Krishnan","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0340","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jcb.10334","article-title":"Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression","volume":"88","author":"Krishnan","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"Suppl. 2","key":"10.1016\/j.mce.2011.05.010_b0335","doi-asserted-by":"crossref","first-page":"V74","DOI":"10.1359\/jbmr.07s213","article-title":"Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity","volume":"22","author":"Krishnan","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/derm.1.1.7106","article-title":"Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer","volume":"1","author":"Krishnan","year":"2009","journal-title":"Dermatoendocrinology"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0350","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ecl.2010.02.011","article-title":"The role of vitamin D in cancer prevention and treatment","volume":"39","author":"Krishnan","year":"2010","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0355","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1124\/jpet.106.115451","article-title":"A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells","volume":"320","author":"Lechner","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.mce.2011.05.010_b0360","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1464-410X.2005.05447.x","article-title":"C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer","volume":"95","author":"Lehrer","year":"2005","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0365","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.urology.2005.08.040","article-title":"Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old","volume":"67","author":"Loeb","year":"2006","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0370","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI110903","article-title":"Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes","volume":"71","author":"Loose","year":"1983","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-0045(19980615)36:1<49::AID-PROS9>3.0.CO;2-6","article-title":"Workgroup I: rodent models of prostate cancer","volume":"36","author":"Lucia","year":"1998","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0380","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1210\/en.140.5.2071","article-title":"Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity","volume":"140","author":"Ly","year":"1999","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.mce.2011.05.010_b0385","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2004.03.003","article-title":"Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells","volume":"221","author":"Ma","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0390","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1158\/1535-7163.MCT-08-0243","article-title":"1Alpha,25-dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model","volume":"7","author":"Ma","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.mce.2011.05.010_b0395","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF03344169","article-title":"Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol)","volume":"29","author":"Maggi","year":"2006","journal-title":"J. Endocrinol. Invest."},{"issue":"25","key":"10.1016\/j.mce.2011.05.010_b0400","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0405","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000093905","article-title":"Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer","volume":"77","author":"McArdle","year":"2006","journal-title":"Urol. Int."},{"issue":"28","key":"10.1016\/j.mce.2011.05.010_b0410","doi-asserted-by":"crossref","first-page":"26365","DOI":"10.1074\/jbc.M010101200","article-title":"Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1","volume":"276","author":"McGuire","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.mce.2011.05.010_b0415","first-page":"6777","article-title":"Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP)","volume":"61","author":"Mentor-Marcel","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.05.010_b0420","first-page":"360","article-title":"Vitamin D and prostate cancer: biological interactions and clinical potentials","volume":"17353","author":"Miller","year":"1999","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0430","first-page":"515","article-title":"The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1\u03b1,25-dihydroxyvitamin D3","volume":"52","author":"Miller","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.05.010_b0425","first-page":"1003","article-title":"Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1\u03b1,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines","volume":"1997","author":"Miller","year":"1995","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0435","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1207\/S15327914NC382_12","article-title":"Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP","volume":"38","author":"Mitchell","year":"2000","journal-title":"Nutr. Cancer"},{"issue":"7","key":"10.1016\/j.mce.2011.05.010_b0440","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2008070692","article-title":"Vascular calcification: the killer of patients with chronic kidney disease","volume":"20","author":"Mizobuchi","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0445","first-page":"695","article-title":"1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines","volume":"5","author":"Moffatt","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.mce.2011.05.010_b0450","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/modpathol.3800142","article-title":"Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia","volume":"17","author":"Montironi","year":"2004","journal-title":"Mod. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.mce.2011.05.010_b0455","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2005.06.012","article-title":"Molecular mechanisms mediating the anti-proliferative effects of vitamin D in prostate cancer","volume":"97","author":"Moreno","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"17","key":"10.1016\/j.mce.2011.05.010_b0460","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1158\/0008-5472.CAN-05-1435","article-title":"Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells","volume":"65","author":"Moreno","year":"2005","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0465","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/cncr.20185","article-title":"High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma","volume":"100","author":"Morris","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2011.05.010_b0470","doi-asserted-by":"crossref","DOI":"10.1210\/en.2009-1156","article-title":"CYP24A1 inhibition enhances the antitumor activity of calcitriol","volume":"151","author":"Muindi","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0475","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/pros.20862","article-title":"Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib","volume":"69","author":"Narayanan","year":"2009","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0480","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1006165017279","article-title":"Model systems of prostate cancer: uses and limitations","volume":"17","author":"Navone","year":"1998","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0485","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jcb.10691","article-title":"Are primary cultures realistic models of prostate cancer?","volume":"91","author":"Peehl","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0500","first-page":"805","article-title":"Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells","volume":"54","author":"Peehl","year":"1994","journal-title":"Cancer Res."},{"issue":"4, Pt. 1","key":"10.1016\/j.mce.2011.05.010_b0490","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-5347(05)64525-9","article-title":"Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells","volume":"168","author":"Peehl","year":"2002","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2004.07.003","article-title":"Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis","volume":"92","author":"Peehl","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0505","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-008-9900-0","article-title":"25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture","volume":"113","author":"Peng","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0510","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1464-410X.2007.07019.x","article-title":"Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel","volume":"100","author":"Petrioli","year":"2007","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0515","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/1097-0045(20001001)45:2<101::AID-PROS3>3.0.CO;2-P","article-title":"Prevention of spontaneous prostate-related cancer in Lobund\u2013Wistar rats by a soy protein isolate\/isoflavone diet","volume":"45","author":"Pollard","year":"2000","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.mce.2011.05.010_b0520","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/jn\/131.10.3191","article-title":"Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth","volume":"132","author":"Rao","year":"2002","journal-title":"J. Nutr."},{"issue":"9339","key":"10.1016\/j.mce.2011.05.010_b0525","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(02)11131-7","article-title":"COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"360","author":"Ray","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2011.05.010_b0530","unstructured":"Report, I., 2010. Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine of the National Academies, November 2010. Available from: <http:\/\/www.iom.edu\/vitamind>."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0535","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/er.20.1.22","article-title":"Molecular genetics and epidemiology of prostate carcinoma","volume":"20","author":"Ruijter","year":"1999","journal-title":"Endocr. Rev."},{"issue":"16","key":"10.1016\/j.mce.2011.05.010_b0540","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2010.32.8815","article-title":"Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer","volume":"29","author":"Scher","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"5A","key":"10.1016\/j.mce.2011.05.010_b0550","first-page":"1307","article-title":"Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis)","volume":"10","author":"Schwartz","year":"1990","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0555","first-page":"391","article-title":"Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3","volume":"7","author":"Schwartz","year":"1998","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"24, Pt. 1","key":"10.1016\/j.mce.2011.05.010_b0545","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1158\/1078-0432.CCR-05-1237","article-title":"Phase I\/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer","volume":"11","author":"Schwartz","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.mce.2011.05.010_b0560","first-page":"1857","article-title":"A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii","volume":"49","author":"Severson","year":"1989","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.mce.2011.05.010_b0565","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/cncr.23806","article-title":"Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001\u20132002 National Health and Nutrition Examination Survey","volume":"113","author":"Singer","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0570","first-page":"678","article-title":"Recent clinical trials of vitamin D3 supplementation and serum calcium levels in humans: implications for vitamin D-based chemoprevention","volume":"11","author":"Skinner","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"5","key":"10.1016\/j.mce.2011.05.010_b0575","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/en.132.5.1952","article-title":"Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines","volume":"132","author":"Skowronski","year":"1993","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.mce.2011.05.010_b0580","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.106.636746","article-title":"Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0585","first-page":"3605","article-title":"A phase II trial of calcitriol and naproxen in recurrent prostate cancer","volume":"29","author":"Srinivas","year":"2009","journal-title":"Anticancer Res."},{"issue":"Suppl.","key":"10.1016\/j.mce.2011.05.010_b0590","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L","article-title":"Localized prostate cancer","volume":"71","author":"Stamey","year":"1993","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0595","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/153537020422900401","article-title":"Vitamin D and prostate cancer","volume":"229","author":"Stewart","year":"2004","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"15","key":"10.1016\/j.mce.2011.05.010_b0600","first-page":"3831","article-title":"Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis","volume":"59","author":"Stewart","year":"1999","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0605","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.juro.2006.08.068","article-title":"Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram","volume":"177","author":"Steyerberg","year":"2007","journal-title":"J. Urol."},{"issue":"18","key":"10.1016\/j.mce.2011.05.010_b0610","first-page":"4014","article-title":"Sunlight \u2013 can it prevent as well as cause cancer?","volume":"55","author":"Studzinski","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.05.010_b0625","article-title":"Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D(3) in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity","volume":"1212","author":"Swami","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1, Suppl.","key":"10.1016\/j.mce.2011.05.010_b0615","doi-asserted-by":"crossref","first-page":"205S","DOI":"10.1093\/jn\/137.1.205S","article-title":"Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer","volume":"137","author":"Swami","year":"2007","journal-title":"J. Nutr."},{"issue":"9","key":"10.1016\/j.mce.2011.05.010_b0620","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/ijc.24161","article-title":"Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients","volume":"124","author":"Swami","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.mce.2011.05.010_b0630","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/1055-9965.EPI-06-0942","article-title":"Chemoprevention of prostate cancer through dietary agents: progress and promise","volume":"16","author":"Syed","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0635","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S0029665108006964","article-title":"The vitamin D receptor in cancer","volume":"67","author":"Thorne","year":"2008","journal-title":"Proc. Nutr. Soc."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0640","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2006.03.025","article-title":"Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3","volume":"247","author":"Ting","year":"2007","journal-title":"Cancer Lett."},{"issue":"1\u20132","key":"10.1016\/j.mce.2011.05.010_b0645","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jsbmb.2005.06.004","article-title":"Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment","volume":"97","author":"Townsend","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4A","key":"10.1016\/j.mce.2011.05.010_b0655","first-page":"2551","article-title":"Vitamin D compounds: clinical development as cancer therapy and prevention agents","volume":"26","author":"Trump","year":"2006","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.mce.2011.05.010_b0660","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/cncr.21890","article-title":"Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer","volume":"106","author":"Trump","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e3181c51ee6","article-title":"Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy","volume":"16","author":"Trump","year":"2010","journal-title":"Cancer J."},{"issue":"3\u20135","key":"10.1016\/j.mce.2011.05.010_b0665","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jsbmb.2006.12.041","article-title":"Regulation of the CYP27B1 5\u2032-flanking region by transforming growth factor-beta in ROS 17\/2.8 osteoblast-like cells","volume":"103","author":"Turner","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.mce.2011.05.010_b0670","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I","article-title":"Use of nude mouse xenograft models in prostate cancer research","volume":"43","author":"van Weerden","year":"2000","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.mce.2011.05.010_b0675","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pros.20595","article-title":"Increased expression of CCAAT\/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation","volume":"67","author":"Wang","year":"2007","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.mce.2011.05.010_b0680","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0960-0760(02)00053-5","article-title":"25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer","volume":"81","author":"Whitlatch","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mce.2011.05.010_b0685","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/01.ju.0000169262.18000.8a","article-title":"Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans","volume":"174","author":"Whittemore","year":"2005","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.mce.2011.05.010_b0690","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1207\/s15327914nc5101_5","article-title":"Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy","volume":"51","author":"Woo","year":"2005","journal-title":"Nutr. Cancer"},{"issue":"47","key":"10.1016\/j.mce.2011.05.010_b0695","doi-asserted-by":"crossref","first-page":"46862","DOI":"10.1074\/jbc.M306340200","article-title":"Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm","volume":"278","author":"Yang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4\u20135","key":"10.1016\/j.mce.2011.05.010_b0700","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jsbmb.2005.11.004","article-title":"Inhibition of vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells","volume":"98","author":"Yee","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.mce.2011.05.010_b0705","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/carcin\/bgh082","article-title":"The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D","volume":"25","author":"Young","year":"2004","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.mce.2011.05.010_b0710","first-page":"8617","article-title":"Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma","volume":"61","author":"Zha","year":"2001","journal-title":"Cancer Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711002516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711002516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T09:49:01Z","timestamp":1712483341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711002516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":140,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0303720711002516"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.05.010","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}